inTEST Co. (NYSE:INTT) is Juniper Investment Company LLC’s 9th Largest Position

Juniper Investment Company LLC trimmed its holdings in shares of inTEST Co. (NYSE:INTT) by 49.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 99,111 shares of the company’s stock after selling 96,938 shares during the quarter. inTEST accounts for approximately 0.3% of Juniper Investment Company LLC’s holdings, making the stock its 9th biggest holding. Juniper Investment Company LLC owned approximately 0.80% of inTEST worth $851,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Royce & Associates LP raised its position in inTEST by 17.5% in the 4th quarter. Royce & Associates LP now owns 1,433,099 shares of the company’s stock worth $12,310,000 after purchasing an additional 213,942 shares during the period. First Eagle Investment Management LLC lifted its stake in shares of inTEST by 2.9% during the 4th quarter. First Eagle Investment Management LLC now owns 602,608 shares of the company’s stock worth $5,176,000 after acquiring an additional 16,744 shares during the last quarter. Pacific Ridge Capital Partners LLC boosted its holdings in inTEST by 6.6% during the 4th quarter. Pacific Ridge Capital Partners LLC now owns 582,483 shares of the company’s stock valued at $5,004,000 after acquiring an additional 36,031 shares during the period. Ameriprise Financial Inc. grew its position in inTEST by 43.2% in the 4th quarter. Ameriprise Financial Inc. now owns 493,524 shares of the company’s stock valued at $4,239,000 after acquiring an additional 148,784 shares during the last quarter. Finally, CM Management LLC lifted its position in shares of inTEST by 4.3% during the fourth quarter. CM Management LLC now owns 365,000 shares of the company’s stock worth $3,135,000 after purchasing an additional 15,000 shares during the last quarter. Hedge funds and other institutional investors own 63.18% of the company’s stock.

Insiders Place Their Bets

In other news, Director Gerald J. Maginnis purchased 7,557 shares of the business’s stock in a transaction on Tuesday, May 6th. The shares were acquired at an average cost of $5.78 per share, with a total value of $43,679.46. Following the completion of the acquisition, the director now owns 78,057 shares of the company’s stock, valued at $451,169.46. This trade represents a 10.72 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 5.50% of the stock is currently owned by corporate insiders.

inTEST Stock Performance

Shares of inTEST stock opened at $6.10 on Friday. inTEST Co. has a 12 month low of $5.24 and a 12 month high of $11.92. The stock’s fifty day moving average price is $6.66 and its 200-day moving average price is $7.64. The firm has a market cap of $76.22 million, a P/E ratio of 26.52 and a beta of 1.63. The company has a current ratio of 2.26, a quick ratio of 1.38 and a debt-to-equity ratio of 0.08.

inTEST (NYSE:INTT) last posted its quarterly earnings results on Friday, May 2nd. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.01). inTEST had a net margin of 2.33% and a return on equity of 5.31%. During the same quarter in the prior year, the business posted $0.10 earnings per share. On average, equities research analysts expect that inTEST Co. will post 0.41 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Lake Street Capital cut their price target on shares of inTEST from $10.00 to $8.00 and set a “buy” rating on the stock in a report on Monday, May 5th. Northland Capmk lowered shares of inTEST from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 5th.

inTEST Profile

inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.